Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam Ferrer

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Cell|April 28, 2023
Cachexia: A systemic consequence of progressive, unresolved diseaseMiriam Ferrer, Tracy G Anthony, Janelle S Ayres, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
JAK1/2 Inhibition Delays Cachexia and Improves Survival through Increased Food IntakeEzequiel Dantas, Anirudh Murthy, Jeshua Kim, et al.
Cell Genomics|August 21, 2023
Cystatin C is glucocorticoid responsive, directs recruitment of Trem2+ macrophages, and predicts failure of cancer immunotherapySam O Kleeman, Tuba Mansoor Thakir, Breanna Demestichas, et al.
Gut|February 11, 2022
Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trialChristina M Brennan, Sandeep Nadella, Xiang Zhao, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Cell|April 28, 2023
Cachexia: A systemic consequence of progressive, unresolved diseaseMiriam Ferrer, Tracy G Anthony, Janelle S Ayres, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
JAK1/2 Inhibition Delays Cachexia and Improves Survival through Increased Food IntakeEzequiel Dantas, Anirudh Murthy, Jeshua Kim, et al.
Cell Genomics|August 21, 2023
Cystatin C is glucocorticoid responsive, directs recruitment of Trem2+ macrophages, and predicts failure of cancer immunotherapySam O Kleeman, Tuba Mansoor Thakir, Breanna Demestichas, et al.
Gut|February 11, 2022
Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trialChristina M Brennan, Sandeep Nadella, Xiang Zhao, et al.
Pageof 3